BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 14644092)

  • 21. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways.
    Kataoka T; Budd RC; Holler N; Thome M; Martinon F; Irmler M; Burns K; Hahne M; Kennedy N; Kovacsovics M; Tschopp J
    Curr Biol; 2000 Jun; 10(11):640-8. PubMed ID: 10837247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p38alpha, but not p38beta, inhibits the phosphorylation and presence of c-FLIPS in DISC to potentiate Fas-mediated caspase-8 activation and type I apoptotic signaling.
    Tourian L; Zhao H; Srikant CB
    J Cell Sci; 2004 Dec; 117(Pt 26):6459-71. PubMed ID: 15572410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells.
    Scaffidi C; Schmitz I; Zha J; Korsmeyer SJ; Krammer PH; Peter ME
    J Biol Chem; 1999 Aug; 274(32):22532-8. PubMed ID: 10428830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adhesion-mediated intracellular redistribution of c-Fas-associated death domain-like IL-1-converting enzyme-like inhibitory protein-long confers resistance to CD95-induced apoptosis in hematopoietic cancer cell lines.
    Shain KH; Landowski TH; Dalton WS
    J Immunol; 2002 Mar; 168(5):2544-53. PubMed ID: 11859150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
    Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
    J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Akt inhibition upregulates FasL, downregulates c-FLIPs and induces caspase-8-dependent cell death in Jurkat T lymphocytes.
    Uriarte SM; Joshi-Barve S; Song Z; Sahoo R; Gobejishvili L; Jala VR; Haribabu B; McClain C; Barve S
    Cell Death Differ; 2005 Mar; 12(3):233-42. PubMed ID: 15665818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW; Shah S
    Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LF 15-0195 immunosuppressive agent enhances activation-induced T-cell death by facilitating caspase-8 and caspase-10 activation at the DISC level.
    Ducoroy P; Micheau O; Perruche S; Dubrez-Daloz L; de Fornel D; Dutartre P; Saas P; Solary E
    Blood; 2003 Jan; 101(1):194-201. PubMed ID: 12393594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of the Fas death pathway by FLICE-inhibitory protein in primary human B cells.
    Hennino A; Berard M; Casamayor-Pallejà M; Krammer PH; Defrance T
    J Immunol; 2000 Sep; 165(6):3023-30. PubMed ID: 10975811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis.
    Mathas S; Lietz A; Anagnostopoulos I; Hummel F; Wiesner B; Janz M; Jundt F; Hirsch B; Jöhrens-Leder K; Vornlocher HP; Bommert K; Stein H; Dörken B
    J Exp Med; 2004 Apr; 199(8):1041-52. PubMed ID: 15078899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracellular mediators of erucylphosphocholine-induced apoptosis.
    Jendrossek V; Müller I; Eibl H; Belka C
    Oncogene; 2003 May; 22(17):2621-31. PubMed ID: 12730676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caspase 8 expression and signaling in Fas injury-resistant human fetal astrocytes.
    Wosik K; Becher B; Ezman A; Nalbantoglu J; Antel JP
    Glia; 2001 Mar; 33(3):217-24. PubMed ID: 11241739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apoptosis induced by disruption of the actin cytoskeleton is mediated via activation of CD95 (Fas/APO-1).
    Kulms D; Düssmann H; Pöppelmann B; Ständer S; Schwarz A; Schwarz T
    Cell Death Differ; 2002 Jun; 9(6):598-608. PubMed ID: 12032668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes.
    Micheau O; Tschopp J
    Cell; 2003 Jul; 114(2):181-90. PubMed ID: 12887920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA class II signals sensitize B lymphocytes to apoptosis via Fas/CD95 by increasing FADD recruitment to activated Fas and activation of caspases.
    Blancheteau V; Charron D; Mooney N
    Hum Immunol; 2002 May; 63(5):375-83. PubMed ID: 11975981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The molecular mechanism of sensitization to Fas-mediated apoptosis by 2-methoxyestradiol in PC3 prostate cancer cells.
    Shimada K; Nakamura M; Ishida E; Kishi M; Matsuyoshi S; Konishi N
    Mol Carcinog; 2004 Jan; 39(1):1-9. PubMed ID: 14694442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular FLIP long form augments caspase activity and death of T cells through heterodimerization with and activation of caspase-8.
    Dohrman A; Russell JQ; Cuenin S; Fortner K; Tschopp J; Budd RC
    J Immunol; 2005 Jul; 175(1):311-8. PubMed ID: 15972663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical sensitization and regulation of TRAIL-induced apoptosis in a panel of B-lymphocytic leukaemia cell lines.
    Kang J; Kisenge RR; Toyoda H; Tanaka S; Bu J; Azuma E; Komada Y
    Br J Haematol; 2003 Dec; 123(5):921-32. PubMed ID: 14632785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
    Suliman A; Lam A; Datta R; Srivastava RK
    Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.